Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
58.74
+0.34 (0.58%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 290 employees as of December 31, 2023. The number of employees increased by 80 or 38.10% compared to the previous year.
Employees
290
Change (1Y)
80
Growth (1Y)
38.10%
Revenue / Employee
$4,776
Profits / Employee
-$891,517
Market Cap
5.29B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
R1 RCM | 30,000 |
Option Care Health | 7,802 |
Merit Medical Systems | 6,950 |
Ultragenyx Pharmaceutical | 1,276 |
Inspire Medical Systems | 1,011 |
Blueprint Medicines | 655 |
Corcept Therapeutics | 352 |
Avidity Biosciences | 253 |
CRNX News
- 14 days ago - Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire
- 16 days ago - Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2024 Earnings Call Transcript - Seeking Alpha